Inhibition of beta-propiolactone-induced mutagenesis and neoplasia by sodium thiosulfate.
Studies have been initiated to find compounds that can trap direct-acting carcinogens within the stomach. Sodium thiosulfate (STS) is a potent nucleophile and in initial experiments was found to inhibit mutagenesis resulting from exposure of Salmonella typhimurium strain TA100 to the direct-acting carcinogens beta-propiolactone and styrene oxide. In in vitro experiments STS was shown to maintain its nucleophilicity in the acid pH range. It reacted with beta-propiolactone as rapidly at pH 2 as at pH 7.4. Thus STS has the prerequisite attributes to inhibit the carcinogenic effects of electrophiles in the stomach. Experiments were performed in which STS was administered by p.o. intubation to female A/J mice 5 min before p.o. administration of beta-propiolactone. Under these conditions, inhibition of formation of the forestomach tumors occurred. The data obtained suggest that use of nucleophiles to protect against direct-acting carcinogens is a potential strategy for chemoprevention.
D000818:Animals; D005260:Female; D006863:Hydrogen-Ion Concentration; D007783:Lactones / Q000633:toxicity*; D051379:Mice; D009154:Mutation; D011420:Propiolactone / Q000633:toxicity*; D013274:Stomach Neoplasms / Q000139:chemically induced / Q000517:prevention & control*; D013885:Thiosulfates / Q000494:pharmacology*
D007783:Lactones; D013885:Thiosulfates; D011420:Propiolactone; C017717:sodium thiosulfate